CMND

← Markets

CMNDClearmind Medicine Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Mon, Aug 24
7:51 AMYahooSciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
7:03 AMstocktitan.netClearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
Thu, Aug 13
6:36 AMYahooClearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
Tue, Aug 11
7:05 AMYahooClearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery
Mon, Aug 3
7:02 AMYahooClearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company
Thu, Jul 30
7:30 AMYahooClearmind Announces Positive Safety Findings for CMND 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation in Part A of its FDA-Regulated Clinical Trial
Tue, Jul 28
6:47 AMYahooClearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
Mon, Jul 20
6:55 AMYahooClearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market
Fri, Jul 17
6:32 AMYahooClearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
Thu, Jul 16
8:30 AMYahooClearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
Mon, Jul 13
7:17 AMYahooClearmind Shares Promising Real-World Insights from Ongoing CMND-100 First-in-Human Trial
Fri, Jul 10
7:32 AMYahooClearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative